Arcus Biosciences Inc
Company Profile
Business description
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Contact
3928 Point Eden Way
Hayward CA 94545
USAT: +1 510 694-6200
E: investorinfo@arcusbio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
577
Stocks News & Analysis
stocks
What next for these 3 high flying ASX shares?
stocks
11 ASX stocks offering great value right now
stocks
ASX stock gets a moat upgrade
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,138.90 | 118.00 | 1.47% |
| CAC 40 | 8,239.99 | 14.20 | 0.17% |
| DAX 40 | 18,869.36 | 152.94 | 0.82% |
| Dow JONES (US) | 39,908.00 | 349.89 | 0.88% |
| FTSE 100 | 8,445.80 | 17.67 | 0.21% |
| HKSE | 19,376.79 | 303.08 | 1.59% |
| NASDAQ | 16,742.39 | 231.21 | 1.40% |
| Nikkei 225 | 38,697.22 | 311.49 | 0.81% |
| NZX 50 Index | 11,699.27 | 173.39 | 1.50% |
| S&P 500 | 5,308.15 | 61.47 | 1.17% |
| S&P/ASX 200 | 7,871.20 | 117.50 | 1.52% |
| SSE Composite Index | 3,134.97 | 15.07 | 0.48% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.13% |
| PYC Therapeutics Ltd PYC | 0.10 | 0.01 | -4.76% |
| Telstra Group Ltd TLS | 3.70 | 0.03 | 0.82% |
| Pantoro Ltd PNR | 0.09 | 0.01 | 9.26% |
| South32 Ltd S32 | 3.73 | 0.06 | 1.50% |
| Pilbara Minerals Ltd PLS | 4.00 | 0.02 | 0.50% |
| Red 5 Ltd RED | 0.49 | 0.02 | 4.26% |
| De Grey Mining Ltd DEG | 1.19 | 0.05 | 4.39% |
| Renascor Resources Ltd RNU | 0.12 | 0.02 | -11.54% |
| Imugene Ltd IMU | 0.07 | 0.00 | 1.43% |